ProQR Therapeutics PRQR
NASDAQ PRQR
$1.40 +0.02 (+1.81%)
As of: Oct 21, 2026 · 11:36 AM EDT

ProQR Therapeutics (PRQR) Notes Payables (2017 - 2021)

Updated

ProQR Therapeutics' Notes Payables came in at $1.35 million for the quarter ended Dec 31, 2020, up 256.4% from $379,662 a year earlier.

Analysis

ProQR Therapeutics (PRQR) Notes Payables (2017 - 2021) Analysis & Trends

As of Dec 31, 2020, ProQR Therapeutics' Notes Payables was $1.3 million, up 237.4% from the prior year.

  • Notes Payables carries a five-year compound annual growth rate of -24.7% (years ended Dec 2015 to Dec 2020).
  • Going back by year, Notes Payables was $384,135 in the year ended Dec 31, 2019 and $2.21 million in the year ended Dec 31, 2017.
  • The figure for the quarter ended Dec 31, 2020 represents the highest quarterly Notes Payables since the quarter ended Dec 31, 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 ProQR Therapeutics 147.99 Mn -312.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 5.40 Mn
Dec 31, 2020 1.40 Mn
Sep 30, 2020 1.11 Mn
Jun 30, 2020 737,816.46
Mar 31, 2020 572,481.21
Dec 31, 2019 384,238.79
Sep 30, 2019 284,510.57
Jun 30, 2019 202,438.36
Jun 30, 2018 2.31 Mn
Dec 31, 2017 2.34 Mn
API Access

ProQR Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=PRQR&period=max&api_key=YOUR_API_KEY